Mccortney Family Hospice, Inc Medicare Approved Location: 117 S Broadway, Ada, Oklahoma 74820 Phone: (580) 332-6900 |
News Archive
Today AIDS Healthcare Foundation praised California State Treasurer Bill Lockyer for sending letters to the CEOs of eight AIDS drug companies—Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck & Co., Tibotec Therapeutics and ViiV Healthcare—urging them to reduce the price of their HIV/AIDS medications for California and its AIDS Drug Assistance Program.
Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first patient enrollment in IN-BALANCE VLU (Inflammation, Bacteria, & Angiogenesis effects in Launching Venous Leg Ulcer healing: A Clinical Evaluation).
Canada's largest non-government funder of arthritis research has announced more than $3.5 million for new arthritis research and training.
According to research presented at the School of Medicine and the University of Navarra Hospital by Dr. Roberto Muñoz, a physician of the Neurology Service of the Hospital Complex of Navarra, those persons with serious cases of sleep apnea have more than twice the possibility of suffering an ischemic stroke. Specifically, 2.5 times more.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
› Verified 7 days ago